Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
53.36 USD | -0.29% | +0.32% | -15.18% |
May. 07 | Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates | MT |
May. 01 | TD Cowen Adjusts Price Target on Incyte to $80 From $88 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.18% | 12.02B | |
-3.35% | 88.91B | |
+2.76% | 41.25B | |
-14.30% | 31.99B | |
+50.51% | 24.73B | |
-15.07% | 15.54B | |
-39.93% | 12.07B | |
-9.08% | 12.05B | |
+6.22% | 8.84B | |
-5.15% | 8.3B |
- Stock Market
- Equities
- INCY Stock
- News Incyte Corporation
- European Medicines Agency Validates Incyte's Marketing Authorization Application For Ruxolitinib Cream